Diagnocure, Inc.
DGCRF · OTC
10/31/2015 | 10/31/2014 | 10/31/2013 | 10/31/2012 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.08 | 0.43 | -0.03 |
| FCF Yield | -23.62% | -38.37% | -14.97% | -16.87% |
| EV / EBITDA | -1.74 | -2.26 | -3.47 | -6.39 |
| Quality | ||||
| ROIC | -102.04% | -40.93% | -51.19% | -35.57% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 60.66% |
| Cash Conversion Ratio | 0.32 | 0.94 | 0.44 | 0.81 |
| Growth | ||||
| Revenue 3-Year CAGR | -8.43% | -39.29% | -18.54% | 27.81% |
| Free Cash Flow Growth | 38.07% | -20.28% | 47.31% | -15.30% |
| Safety | ||||
| Net Debt / EBITDA | 0.20 | 0.72 | 0.52 | 0.30 |
| Interest Coverage | -256.68 | -207.49 | -376.32 | -306.32 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 128.04 | 151.56 | 137.22 | -50.35 |